Outlook Therapeutics Statistics
Total Valuation
OTLK has a market cap or net worth of $176.78 million. The enterprise value is $202.96 million.
| Market Cap | 176.78M |
| Enterprise Value | 202.96M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLK has 21.58 million shares outstanding. The number of shares has increased by 14.44% in one year.
| Shares Outstanding | 21.58M |
| Shares Change (YoY) | +14.44% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 38.85% |
| Owned by Institutions (%) | 22.74% |
| Float | 5.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.85 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.44
| Current Ratio | 0.44 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 48.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -135.10% |
| Return on Capital (ROIC) | -391.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.15M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, OTLK has paid $2,800 in taxes.
| Income Tax | 2,800 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.43% in the last 52 weeks. The beta is 0.19, so OTLK's price volatility has been lower than the market average.
| Beta (1Y) | 0.19 |
| 52-Week Price Change | -62.43% |
| 50-Day Moving Average | 8.51 |
| 200-Day Moving Average | 11.92 |
| Relative Strength Index (RSI) | 45.50 |
| Average Volume (30 Days) | 642,114 |
Short Selling Information
The latest short interest is 1.13 million, so 5.23% of the outstanding shares have been sold short.
| Short Interest | 1.13M |
| Short Previous Month | 1.33M |
| Short % of Shares Out | 5.23% |
| Short % of Float | 19.23% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -47.76M |
| Pretax Income | -51.50M |
| Net Income | -51.50M |
| EBITDA | -52.51M |
| EBIT | -52.57M |
| Earnings Per Share (EPS) | -$4.00 |
Balance Sheet
The company has $10.36 million in cash and $36.55 million in debt, giving a net cash position of -$26.19 million or -$1.21 per share.
| Cash & Cash Equivalents | 10.36M |
| Total Debt | 36.55M |
| Net Cash | -26.19M |
| Net Cash Per Share | -$1.21 |
| Equity / Book Value | -24.34M |
| Book Value Per Share | -1.13 |
| Working Capital | -25.58M |
Cash Flow
| Operating Cash Flow | -47.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -47.10M |
| FCF Per Share | -$3.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.44% |
| Shareholder Yield | -14.44% |
| Earnings Yield | -29.13% |
| FCF Yield | -26.65% |
Analyst Forecast
The average price target for OTLK is $46.43, which is 466.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.43 |
| Price Target Difference | 466.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |